Bimekizumab versus Ustekinumab Efficacy Across Subgroups of Patients with Moderate to Severe Plaque Psoriasis: Results from the Multicenter, Randomized, Double-Blinded Phase 3 BE VIVID Trial. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 5, n. 1, p. s16, 2021. DOI: 10.25251/skin.5.supp.16. Disponível em: https://skin.dermsquared.com/skin/article/view/1169. Acesso em: 1 may. 2026.